1.Syndrome of Inappropriate Antidiuretic Hormone Secretion in a Patient with Large Cell Neuroendocrine Carcinoma.
Hyung Jung OH ; Mi Jung LEE ; Seon Jung JANG ; Dong Ho SHIN ; Shin Wook KANG
Yonsei Medical Journal 2012;53(3):667-669
The syndrome of inappropriate antidiuretic hormone secretion has only been reported in a few patients with large cell neuroendocrine carcinoma (LCNEC); however, it has never been reported in a patient with LCNEC of the lung, whose serum sodium levels were normalized after surgical resection of the mass. A 63-year-old male presented with a two-day history of dizziness and recent memory loss. On admission, his serum sodium level was 113 mEq/L with a serum osmolality of 236 mosm/kg, a urine osmolality of 441 mosm/kg, and a urine sodium level of 65 mEq/L. His chest computed tomography revealed a 2.7x2.3 cm-sized mass in the left lower lobe. After surgical removal of the mass, his serum sodium concentrations were normalized, and histopathology of the mass revealed LCNEC.
Carcinoma, Large Cell/*pathology
;
Carcinoma, Neuroendocrine/*pathology
;
Humans
;
Inappropriate ADH Syndrome/*pathology
;
Male
;
Middle Aged
4.The Radiotherapeutic Significance of Serum NSE Level in Non-Small Cell Lung Cancers (NSCLC).
San Mo YUN ; Sang Bo KIM ; In Kyu PARK ; Tae Hoon JUNG
Journal of the Korean Society for Therapeutic Radiology 1994;12(1):73-80
From December 1989 to February 1993, 108 patients with Non-Small Cell Lung Cancers(NSCLC) were studied retrospectively to evaluate radiotherapeutic significance of serum levels of NSE. We considered elevated serum neuron specific pathologic evaluation revealed 86 squamous cell carcinomas, 11 adenocarcinomas, 3 large cell carcinomas, 3 mucoepidermoid carcinomas, and 5 unknown pathology. Eight patients had stageI, 40 stage III A, and 60 stageIII B. S-NSE level greater than 15 ng/ml was considered as elevated, and below this considered as normal. All patients received radiotherapy as primary treatment modality. The responders to radiotherapy had significantly higher mean S-NSE level than on-responders (28.5 ng/ml vs 20 ng/ml, p=0.01). Overall 2-year survival rate (YSR) was 23.6%. According to radiotherapy response, 2 YSR for patients with CR, PR, and NR were 39.2%, 28.6%, and 6.2% respectively (p=0.001). 2 YSR for patients with elevated and normal S-NSE were 14.6% and 31.7%(p=0.02). The patients with NR showed no difference in survival according to S-NSE level. When we considered all patients, S-NSE level showed no significant impact on response. But for squamous cell cardinomas alone, patients with elevated S-NSE had more patients with higher nodal stage. Based on our and other data, NSCLSC with neuroendocrine features have different response to treatment and clinical behavior compared to other NSCLSC. Thus, this subgroup may need different treatment modality, and S-NSE level may have prognostic significance.
Adenocarcinoma
;
Carcinoma, Large Cell
;
Carcinoma, Mucoepidermoid
;
Carcinoma, Squamous Cell
;
Humans
;
Lung Neoplasms*
;
Lung*
;
Neurons
;
Pathology
;
Phosphopyruvate Hydratase
;
Radiotherapy
;
Retrospective Studies
;
Survival Rate
5.A Case of Large Cell Neuroendocrine Carcinoma of the Colon.
Hi Gu KIM ; Jung Il LEE ; Seok JEONG ; Jin Woo LEE ; Kye Sook KWON ; Hyung Gil KIM ; Yong Woon SHIN ; Lucia KIM
The Korean Journal of Gastroenterology 2009;54(1):46-49
Neuroendocrine carcinoma of the colon can be classified into small cell carcinoma and large cell neuroendocrine carcinoma. The incidence of neuroendocrine carcinoma is so low that the guideline for the treatment of large cell neuroendocrine carcinoma of the colon are not established. The prognosis of large cell neuroendocrine carcinoma of the colon is worse than that of conventional adenocarcinoma of the colon. We report a case of large cell neuroendocrine carcinoma of the colon that treated with right hemicolectomy and 6th sequential combination chemotherapy of 5-fluorouracil and cisplatin. There has been no evidence of the recurrence or metastasis of tumor for 6 months.
Adult
;
Carcinoma, Large Cell/*diagnosis/pathology/radiography
;
Carcinoma, Neuroendocrine/*diagnosis/pathology/radiography
;
Colonic Neoplasms/*diagnosis/pathology/radiography
;
Colonoscopy
;
Humans
;
Male
;
Tomography, X-Ray Computed
6.Primary Large Cell Neuroendocrine Carcinoma of the Breast: Radiologic and Pathologic Findings.
Jin Woo KIM ; Ok Hee WOO ; Kyu Ran CHO ; Bo Kyung SEO ; Hwan Seok YONG ; Aeree KIM ; Eun Young KANG
Journal of Korean Medical Science 2008;23(6):1118-1120
Some breast neoplasms are classified as primary neuroendocrine carcinomas because they are positive for neuroendocrine markers. Although neuroendocrine carcinomas can originate from various organs of the body, primary neuroendocrine carcinomas of the breast are extremely rare. The diagnosis of primary neuroendocrine carcinoma of the breast can only be made if nonmammary sites are confidently excluded or if an in situ component can be found. Here we report a primary large-cell neuroendocrine carcinoma (LCNL) involving the left breast. Breast ultrasonography revealed a lobulated, heterogeneous, low-echoic mass in the left breast, and the lesion ap-peared as a well-defined, highly-enhancing mass on a chest computed tomography scan. Ultrasound-guided core needle biopsy was performed on the mass, and primary LCNC was confirmed by histopathologic examination.
Adult
;
Breast Neoplasms/*diagnosis/pathology/ultrasonography
;
Carcinoma, Large Cell/*diagnosis/pathology/radiography
;
Carcinoma, Neuroendocrine/*diagnosis/pathology/radiography
;
Diagnosis, Differential
;
Female
;
Humans
;
Tomography, X-Ray Computed
7.Histiocytic sarcoma of stomach: report of a case.
Ting FENG ; Miao-xia HE ; Wei-yong GU ; Chen-guang BAI ; Da-lie MA ; Jian-ming ZHENG ; Ming-hua ZHU
Chinese Journal of Pathology 2012;41(2):130-131
Aged
;
Antigens, CD
;
metabolism
;
Antigens, Differentiation, Myelomonocytic
;
metabolism
;
Carcinoma, Large Cell
;
metabolism
;
pathology
;
Diagnosis, Differential
;
Histiocytic Sarcoma
;
metabolism
;
pathology
;
surgery
;
Hodgkin Disease
;
metabolism
;
pathology
;
Humans
;
Lymphoma, Large B-Cell, Diffuse
;
metabolism
;
pathology
;
Lymphoma, Large-Cell, Anaplastic
;
metabolism
;
pathology
;
Male
;
Melanoma
;
metabolism
;
pathology
;
Receptors, Cell Surface
;
metabolism
;
Stomach Neoplasms
;
metabolism
;
pathology
;
surgery
8.Biological behaviors of lung cancer stem-like cells from human large-cell lung cancer cell line H460.
Journal of Southern Medical University 2014;34(4):453-462
OBJECTIVETo isolate lung cancer stem-like cells (LCSCs) from human large-cell lung cancer cell line NCI-H460 (H460) and explore their biological characteristics.
METHODSH460 cells were cultured in serum-free medium in the presence of specific growth factors. Quantitative PCR (qPCR), flow cytometry and colony formation assay were performed to characterize the stemness of H460 spheres. Adherent H460 cells and H460 cell spheres were inoculated subcutaneously in nude mice and the tumor growth was assessed.
RESULTSThe isolated LCSCs from H460 cells in serum-free medium grew as floating cell spheres and exhibited stronger proliferative activity than H460 cells. Compared with H460 cells, H460 cells spheres showed higher expressions of stem cell markers Sox2, Oct4, and especially Nanog, and possessed a stronger tumorigenicity in nude mice.
CONCLUSIONThe serum-free culture system can effectively enrich lung cancer stem cells from human lung cancer stem cell line H460, and the high expression of Nanog may importantly contribute to the maintenance of cancer stem cell-like properties of the isolated LCSCs.
Animals ; Carcinoma, Large Cell ; pathology ; Cell Line, Tumor ; Culture Media, Serum-Free ; Humans ; Lung Neoplasms ; pathology ; Male ; Mice ; Mice, Nude ; Neoplastic Stem Cells ; cytology
9.Contemporary approach to diagnosis and classification of renal cell carcinoma with mixed histologic features.
Kanishka SIRCAR ; Priya RAO ; Eric JONASCH ; Federico A MONZON ; Pheroze TAMBOLI
Chinese Journal of Cancer 2013;32(6):303-311
Renal cell carcinoma (RCC) is an important contributor to cancer-specific mortality worldwide. Targeted agents that inhibit key subtype-specific signaling pathways have improved survival times and have recently become part of the standard of care for this disease. Accurately diagnosing and classifying RCC on the basis of tumor histology is thus critical. RCC has been traditionally divided into clear-cell and non-clear-cell categories, with papillary RCC forming the most common subtype of non-clear-cell RCC. Renal neoplasms with overlapping histologies, such as tumors with mixed clear-cell and papillary features and hybrid renal oncocytic tumors, are increasingly seen in contemporary practice and present a diagnostic challenge with important therapeutic implications. In this review, we discuss the histologic, immunohisto-chemical, cytogenetic, and clinicopathologic aspects of these differential diagnoses and illustrate how the classification of RCC has evolved to integrate both the tumor's microscopic appearance and its molecular fingerprint.
Biopsy, Large-Core Needle
;
Carcinoma, Renal Cell
;
classification
;
diagnosis
;
genetics
;
pathology
;
DNA Copy Number Variations
;
DNA, Neoplasm
;
genetics
;
Diagnosis, Differential
;
Humans
;
Kidney Neoplasms
;
classification
;
diagnosis
;
genetics
;
pathology
10.Expression and clinicopathologic significance of human achaete-scute homolog 1 in pulmonary neuroendocrine tumors.
Fei LI ; Zhiyong ZHONG ; Rui LI ; Heyu HUANG ; Lijun WANG ; Donghan ZHENG ; Daorong ZHANG
Chinese Journal of Lung Cancer 2010;13(4):317-321
BACKGROUND AND OBJECTIVEHuman achaete-scute homolog 1 (hASH1) gene plays a critical role in development of the central nervous system, automatic nervous system, adrenal medullary chromaffin cells, thyroid C cells and pulmonary neuroendocrine cells. The aim of this study is to determine hASH1 gene expression in the normal lung tissue and various types of lung tumors, to analyze whether its expression correlated with pulmonary neuroendocrine markers, and to explore the possibility of hASH1 as clinical pathological markers in the neuroendocrine tumors compared with previous neuroendocrine tumor markers.
METHODShASH1, Chromogranin A, Synaptophysin and CD56 expression were examined in lung tumor specimens (lung inflammatory pseudotumor, squamous cell carcinoma, adenocarcinomas, large cell carcinoma, typical carcinoids, atypical carcinoids, large cell neuroendocrine carcinomas and small cell lung carcinoma and corresponding normal lung specimens) using immunohistochemistry (S-P method). Western blot and reverse transcription polymerase chain reaction (RT-PCR) assay were applied to detect the expressions of hASH1 protein and mRNA in lung cancer tissues.
RESULTShASH1 expression was positive in 2/16 (12.5%) typical carcinoids, 15/20 (75%) atypical carcinoids, 6/10 (60%) large cell neuroendocrine carcinomas and 31/40 (77.5%) small cell lung carcinoma, respectively, but not in any normal lung tissue (0/10), lung inflammatory pseudotumor (0/49), squamous cell carcinoma (0/30), adenocarcinomas (0/30) or large cell carcinoma (0/20). There was a significant difference in hASH1 expression between typical carcinoids and atypical carcinoids (P < 0.01), but not in large cell neuroendocrine carcinomas and small cell lung carcinoma (P > 0.05). hASH1 expression highly closely correlated with Chromogranin A, Synaptophysin and CD56 expression (P < 0.05).
CONCLUSIONhASH1 is a new kind of highly specific markers of pulmonary neuroendocrine tumours, and may be applied to clinical pathology diagnosis of the pulmonary neuroendocrine tumors.
Adenocarcinoma ; genetics ; metabolism ; pathology ; Basic Helix-Loop-Helix Transcription Factors ; genetics ; metabolism ; Carcinoma, Large Cell ; genetics ; metabolism ; pathology ; Carcinoma, Neuroendocrine ; genetics ; metabolism ; pathology ; Carcinoma, Squamous Cell ; genetics ; metabolism ; pathology ; Gene Expression Regulation, Neoplastic ; genetics ; physiology ; Humans ; Immunohistochemistry ; Lung Neoplasms ; genetics ; metabolism ; pathology ; Neuroendocrine Tumors ; genetics ; metabolism ; pathology ; Reverse Transcriptase Polymerase Chain Reaction ; Small Cell Lung Carcinoma ; genetics ; metabolism ; pathology